Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioScrip Inc sees FY 2014 revenue guidance at high end of prior range; reaffirms FY 2014 EBITDA guidance

Wednesday, 6 Aug 2014 04:30pm EDT 

BioScrip Inc:Projects that its FY 2014 revenue will be at high end of its guidance range of $940.0 mln to $980.0 mln and that its FY 2014 adjusted EBITDA will be in range of $55.0 mln to $60.0 mln.FY 2014 revenue of $966.2 mln - Thomson Reuters I/B/E/S. 

Company Quote

-0.1 -1.28%
11:33am EDT